A Trial Of Approach Bias Modification Training During Treatment For Cocaine Use Disorder
NCT07033416, Not applicable, Recruiting, ASST Fatebenefratelli Sacco
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | A Trial Of Approach Bias Modification Training During Treatment For Cocaine Use Disorder | ClinicalTrials.gov |
| NCT number | NCT07033416 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 60 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | ASST Fatebenefratelli Sacco | ClinicalTrials.gov |
| Conditions | Training for Cocaine Use Disorder | ClinicalTrials.gov |
| Interventions | Approach Bias Modification, Treatment as usual | ClinicalTrials.gov |
| First posted | 2025-06-24 | ClinicalTrials.gov |
| Last updated | 2025-12-24 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Abstinence days from cocaine after 4 Approach Bias Modification (ABM) training sessions | Urine analysis from enrollment to the end of treatment twice a week,in the first three weeks. TLFB at 1 and 3 months after the end of training. | Abstinence days from cocaine measured by urine analysis and a self-report questionnaire (Timeline Follow-Back, TLFB) measuring frequency and quantity of cocaine use and route of administration. | ClinicalTrials.gov |
| Secondary | Operationalisation of continuous abstinence in participants trained with ABM, relative to TAU. | at 1 and 3 months after the end of training. | Operationalisation of continuous abstinence is assessed by urine analysis and self-report questionnaires: • Craving Experience Questionnaire (CEQ): two 10-item scales, one measuring the frequency of cravings over a defined time period, and the other assessing the strength of the strongest cravings during this period. | ClinicalTrials.gov |
| Secondary | Operationalisation of continuous abstinence in participants trained with ABM, relative to TAU | at 1 and 3 months after the end of training | Severity of Dependence Scale (SDS): a continuous measure of psychological dependence on cocaine. A score of zero is assigned to no cocaine use during the past month. | ClinicalTrials.gov |
| Secondary | Operationalisation of continuous abstinence in participants trained with ABM, relative to TAU. | at 1 and 3 months after the end of training | Operationalisation of continuous abstinence is assessed by urine analysis and self-report questionnaires: Timeline Follow-back (TLFB): a measure of frequency and quantity of cocaine use and route of administration | ClinicalTrials.gov |
| Secondary | Operationalisation of continuous abstinence in participants trained with ABM, relative to TAU. | at 1 month after the end of training | Operationalisation of continuous abstinence is assessed by urine analysis and self-report questionnaires: Modified Stroop Task for Addiction (MST): a 0-to-100 scale measuring attention regulation and suppression of interference due to semantic incongruence or salience of addiction-related stimuli. | ClinicalTrials.gov |
| Secondary | Operationalisation of continuous abstinence in participants trained with ABM, relative to TAU. | at 1 month after the end of training | Operationalisation of continuous abstinence is assessed by urine analysis and self-report questionnaires: Modified Go/No-go Task for Addiction (MGNT): a measure of suppression of pre-potent responses and control of attention bias for salient stimuli associated with addiction-related. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Go/No-Go Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)